EUVIMEDEUVIMED entdecken
Open Access

Dominant-negative TP53 mutations potentiated by the HSF1-regulated proteostasis network

Stephanie Halim, Rebecca M Sebastian, Kristi E Liivak, Jessica E Patrick, Tiffani Hui, David R Amici, Andrew O Giacomelli, Paulina Rios, Vincent L Butty, William C Hahn, Francisco J Sánchez-Rivera, Marc L Mendillo und 2 weitere

Molecular Cell · 2026

DOI: 10.1016/j.molcel.2025.12.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Cell, 2026. Verfasst von Stephanie Halim und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Heat Shock Transcription Factors, Proteostasis, Mutation. Die Arbeit nennt 110 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS, NIGMS NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protein mutational landscapes are shaped by how amino acid substitutions affect stability and folding or aggregation kinetics. These properties are modulated by cellular proteostasis networks. Heat shock factor 1 (HSF1) is the master regulator of cytosolic and nuclear proteostasis. Chronic HSF1 activity upregulation is a hallmark of cancer cells, potentially because upregulated proteostasis factors facilitate the acquisition and maintenance of oncogenic mutations. Here, we assess how HSF1 activation influences mutational trajectories by which p53 can escape cytotoxic pressure from nutlin-3, an inhibitor of the p53 regulator mouse double minute 2 homolog (MDM2). HSF1 activation broadly increases the fitness of dominant-negative p53 substitutions, particularly non-conservative, biophysically unfavorable amino acid changes within buried regions of the p53 DNA-binding domain. These findings demonstrate that HSF1 activation reshapes the oncogenic mutational landscape by preferentially supporting the emergence and persistence of biophysically disruptive, cancer-associated p53 substitutions, linking proteostasis network activity directly to oncogenic evolution.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Suppressor Protein p53Heat Shock Transcription FactorsProteostasisMutationHumansProto-Oncogene Proteins c-mdm2PiperazinesImidazolesAnimalsCell Line, TumorAmino Acid SubstitutionProteotoxic Stress

Stichwörter der Autor:innen

HSP70HSP90cancer evolutionchaperonesdeep mutational scanningheat shock factor Imutational bufferingp53protein foldingproteostasis

Substanzen

Tumor Suppressor Protein p53Heat Shock Transcription FactorsHSF1 protein, humanProto-Oncogene Proteins c-mdm2Piperazinesnutlin 3TP53 protein, humanImidazolesMDM2 protein, human

Autor:innen und Institutionen

  • Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Department of Chemistry, Tufts University, Medford, MA 02155, USA.
  • Department of Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA; Simpson Querrey Institute for Epigenetics, Northwestern University Feinberg School of Medic…
  • Humber Polytechnic, Toronto, ON M9W 5L7, Canada.
  • Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; BioMicro Center, M…

Förderung

  • NIEHS NIH HHS
  • NIGMS NIH HHS
  • NCI NIH HHS
  • NIAID NIH HHS
  • Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
  • Howard Hughes Medical Institute
  • Massachusetts Institute of Technology
  • V Foundation

Zitieren

APA

Halim, S., Sebastian, R. M., Liivak, K. E., Patrick, J. E., Hui, T., Amici, D. R., Giacomelli, A. O., Rios, P., Butty, V. L., Hahn, W. C., Sánchez-Rivera, F. J., Mendillo, M. L., Lin, Y. S., & Shoulders, M. D. (2026). Dominant-negative TP53 mutations potentiated by the HSF1-regulated proteostasis network. Molecular Cell. https://doi.org/10.1016/j.molcel.2025.12.013

Vancouver

Halim S, Sebastian RM, Liivak KE, Patrick JE, Hui T, Amici DR, et al. Dominant-negative TP53 mutations potentiated by the HSF1-regulated proteostasis network. Molecular Cell. 2026. doi:10.1016/j.molcel.2025.12.013

BibTeX
@article{Halim2026,
  author = {Halim, Stephanie and Sebastian, Rebecca M and Liivak, Kristi E and Patrick, Jessica E and Hui, Tiffani and Amici, David R and Giacomelli, Andrew O and Rios, Paulina and Butty, Vincent L and Hahn, William C and Sánchez-Rivera, Francisco J and Mendillo, Marc L and Lin, Yu-Shan and Shoulders, Matthew D},
  title = {Dominant-negative TP53 mutations potentiated by the HSF1-regulated proteostasis network},
  journal = {Molecular Cell},
  year = {2026},
  doi = {10.1016/j.molcel.2025.12.013}
}
Kostenlos starten →